logo
logo

Ocudyne, Inc. announced it raised $463,000 in an initial filing from an offering of $500,000

Ocudyne, Inc. announced it raised $463,000 in an initial filing from an offering of $500,000

10/20/16, 4:37 PM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgbrooklyn park
Money raised
$463,000
Industry
health care
Round Type
seed

Company Info

Company
Ocudyne
Location
7600 boone avenue north, suite #7
brooklyn park, minnesota, united states
Additional Info
OcuDyne is a clinical-stage medical device company developing a novel therapy to treat Age Related Macular Degeneration (AMD), the leading cause of irreversible vision loss in the elderly worldwide. As a world leader in the evaluation of ocular perfusion and how it influences ocular health, OcuDyne’s mission is to develop therapies that improve blood flow to the eye. Impaired blood flow causes disease in organ systems all over the body, and the eye is no exception. Over the past few years, advances in intracranial and arterial imaging have shown that impared ocular perfusion is present in patients suffering from AMD. As a result, AMD is the first indication being pursued by OcuDyne.

Related People